(A) Five intrachromosomal rearrangements of chromosome 16q including the NUDT21 gene, identified by clinical array comparative genomic hybridization. Duplications shown in blue, deletion in red. …
(A) Representative western blot picture for three duplication patients compared to four age-matched controls showing the increase of CFIm25 and decrease of MeCP2 protein levels. (B) Representative …
(A) Representative histograms of control (i) and siGLO-nucleofected lymphoblastoid cells showing nearly 100% efficiency using both the functionality (ii) and efficiency (iii) protocols. (B) Time …
(A) RNA quantification by quantitative RT-polymerase chain reaction (qRT-PCR) from lymphoblastoid cells of NUDT21 duplication and deletion patients. The bar graph shows the total mRNA fold change of …
Northern blot assay of lymphoblastoid cells showing that duplication (left panel) and deletion (right panel) patients respectively have more long or short MECP2 3′ UTR isoforms. Relative northern …
Representative polyribosome traces from control (A-C) and duplication (D-F) subjects. UV absorption at 254 nm was plotted vs time depicting the successful resolution of the different ribosomal …
Northern blot assay showing that duplication and deletion patients respectively have more long or short MECP2 isoforms (left panel). Quantification of three duplication patients and one deletion …
Molecular and clinical characteristics of four individuals with NUDT21 duplication and one individual with NUDT21 deletion
Subject 1 | Subject 2 | Subject 3 | Subject 4 | Subject 5 | |
---|---|---|---|---|---|
Sex | F | M | M | F | F |
Age | 10 years | 5 years | 15 years | 13 years | 8 years |
Deletion/duplication | Duplication | Duplication | Duplication | Deletion | Duplication |
Coordinates | chr16: 46,500,741-64,653,093 | chr16: 46,500,741-58,539,422 | chr16: 55,725,264-57,533,101 | chr16: 56,344,856-63,521,523 | chr16: 55,919,145-56,619,283 |
Size | 18.15 Mb | 12.04 Mb | 1.81 Mb | 7.18 Mb | 0.70 Mb |
Zygosity | Heterozygous | Heterozygous | Mosaic marker chromosome (present in 45% of cells) | Heterozygous | Heterozygous |
Inheritance | De novo | De novo | De novo | Unknown | Not maternal* |
Additional CNVs | 52 kb duplication of chr6: 152, 716, 341-152, 768, 421 (maternal) | None | None | 144 kb duplication of chr17: 427, 284-571, 275 (inheritance unknown) | None |
Developmental delay/intellectual disability | Intellectual disability (clinical impression: moderate) | Significant developmental delay | Intellectual disability | Intellectual disability (full scale IQ 53) | Intellectual disability |
Developmental regression | Yes, at 2 years of age | No | Yes | No | No |
Autism spectrum disorder | Yes | No | Yes | No | Yes |
Epilepsy | Single, isolated seizure at 5 years of age | No | No | Intractable, symptomatic partial onset seizures | No |
ADHD | Yes | Yes | Unknown | Yes | No |
F, female; M, male; chr, chromosome; MB, megabases; CNVs, copy number variants; kb, kilobases; ADHD, attention deficit hyperactivity disorder.
Father not available.